Group Post |
One key step toward solving the nation’s deadly nursing shortage |
FNUOvviyaa |
Group Post |
Covid: UK first country to approve dual-strain vaccine |
FNUOvviyaa |
Group Post |
Health Care — Pfizer to expand domestic manufacturing of Paxlovid |
FNUOvviyaa |
Group Post |
Gottlieb: Drug shortage ‘isn’t like what we had with baby formula’ |
FNUOvviyaa |
Group Post |
The extraordinary success of Covid-19 vaccines, in two charts |
FNUOvviyaa |
Group Post |
What the end of the COVID-19 national emergency means |
FNUOvviyaa |
Group Post |
Monkeypox: WHO declares highest alert over outbreak |
FNUOvviyaa |
Group Post |
Nonprofits launch $100M plan to support local health workers |
FNUOvviyaa |
Group Post |
Officials Lament Barriers to Monkeypox Treatments, Prevention |
FNUOvviyaa |
Group Post |
Fauci on needing a second generation of COVID vaccines: 'We have multiple variants of concern ... And it's getting more complicated' |
FNUOvviyaa |
Group Post |
‘Silent’ spread of polio in New York drives CDC to consider additional vaccinations for some people |
FNUOvviyaa |
Group Post |
Gridlock could delay COVID funds until fall — or longer |
FNUOvviyaa |
Group Post |
Over 40 million health professionals demand bold health and climate action at COP28 |
FNUOvviyaa |
Group Post |
Trends are shifting, but Covid-19 and its effects are still not equitable |
FNUOvviyaa |
Group Post |
China's Xian imposes temporary, partial lockdown to fight Omicron flare-up |
FNUOvviyaa |
Group Post |
Flu and RSV on the decline but Covid hospitalizations rise |
FNUOvviyaa |
Group Post |
Patient, Beware: Some States Still Pushing Ineffective Covid Antibody Treatments |
FNUOvviyaa |
Group Post |
Second high-level interregional meeting on the health of refugees and migrants |
FNUOvviyaa |
Group Post |
AMA chief says mask mandates becoming more likely amid ‘pretty scary’ Covid hospital numbers |
FNUOvviyaa |
Group Post |
Spain reports second monkeypox death |
FNUOvviyaa |
Group Post |
Trials of new Covid vaccine raise hopes of once-a-year booster |
FNUOvviyaa |
Group Post |
Uganda gets Ebola vaccine doses for trial on Sudan strain |
FNUOvviyaa |
Group Post |
WHO says it is analysing two new Omicron COVID sub-variants |
FNUOvviyaa |
Group Post |
Long COVID: What scientists have learned about the symptoms affecting millions around the world |
FNUOvviyaa |
Group Post |
'Natural Immunity' Holds Up Against Severe Omicron Cases in Qatar Study |
FNUOvviyaa |
Recent Comments